VENEZIANI, BIANCA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.431
EU - Europa 1.161
AS - Asia 295
AF - Africa 33
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.924
Nazione #
US - Stati Uniti d'America 1.368
IT - Italia 519
CN - Cina 257
FR - Francia 122
FI - Finlandia 111
IE - Irlanda 107
NL - Olanda 100
DE - Germania 91
UA - Ucraina 68
CA - Canada 63
CI - Costa d'Avorio 33
IN - India 20
GB - Regno Unito 19
SE - Svezia 17
VN - Vietnam 12
ES - Italia 2
IR - Iran 2
PK - Pakistan 2
AP - ???statistics.table.value.countryCode.AP??? 1
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
HR - Croazia 1
MK - Macedonia 1
RS - Serbia 1
SA - Arabia Saudita 1
SG - Singapore 1
Totale 2.924
Città #
Chandler 209
Napoli 176
Jacksonville 117
Princeton 112
Amsterdam 100
Millbury 96
Nanjing 93
Boston 77
Ashburn 75
Naples 63
Ottawa 62
Wilmington 62
Beijing 43
Nanchang 25
Des Moines 22
Falls Church 21
Hebei 21
Norwalk 20
Woodbridge 19
Tianjin 18
Pune 16
Dublin 15
Hicksville 14
Shenyang 14
Changsha 13
Dong Ket 12
Redwood City 12
Palma Campania 10
Jiaxing 9
Ann Arbor 8
Milan 8
San Mateo 8
Hangzhou 7
Boardman 6
Kunming 6
New York 6
Redmond 6
Rome 6
Florence 5
Formia 5
Indiana 5
Salerno 5
Caserta 4
Kronberg 4
Montecorvino Rovella 4
Seattle 4
Casoria 3
Giugliano In Campania 3
Leawood 3
Marano Di Napoli 3
Villaricca 3
Afragola 2
Alpignano 2
Angri 2
Ardabil 2
Augusta 2
Changchun 2
Dallas 2
Dearborn 2
Fremont 2
Lahore 2
Lanzhou 2
London 2
Matera 2
Orange 2
Pomigliano d'Arco 2
Sarno 2
Shanghai 2
Villarosa 2
Washington 2
Ancona 1
Bacoli 1
Bari 1
Baronissi 1
Bologna 1
Bovisio Masciago 1
Casalnuovo 1
Casalnuovo Di Napoli 1
Castel Volturno 1
Castelli Calepio 1
Centrale 1
Charlotte 1
Chilliwack 1
Colle Di Val D'elsa 1
Cologno Monzese 1
Duncan 1
Eboli 1
Esslingen am Neckar 1
Fairfield 1
Forlì 1
Giugliano in Campania 1
Granada 1
Helsinki 1
Houston 1
La Canada Flintridge 1
Lappeenranta 1
Lucca 1
Maranello 1
Marano di Napoli 1
Marcianise 1
Totale 1.726
Nome #
Progetto dimostratore di analisi dei tessuti: BIONCAM BIObanca ONcologica CAMpania 192
Epigenetic silencing of THY1 tracks the acquisition of the Notch1-EGFR signaling in a xenograft model of CD44+/CD24low/CD90+ myoepithelial cells 89
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors 84
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 82
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers 55
1599P - Effects of Hedgehog signaling inhibition on epithelial-stromal interactions in triple negative breast cancer cells 53
Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results 50
Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells. 49
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status 46
Epidermal growth factor receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. 44
Alterations of autophagy in the peripheral neuropathy Charcot-Marie-Tooth type 2B 44
The Epithelial-Stromal Interaction as a Potential Target for Breast Cancer Treatment 42
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. 41
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. 40
Tranfected Insulin- like growth factor II modulates the mitogenic response of rat thyrocytes in culture 39
ANTITUMOR ACTIVITY OF THE COMBINATION OF CETUXIMAB, AN ANTI-EGFR BLOCKING MONOCLONAL ANTIBODY AND ZD6474, AN INHIBITOR OF VEGFR AND EGFR TYROSINE KINASES. 38
Antitumor effects of ZD6474, a small molecule Vascular Endothelial Growth Factor receptor tyrosine kinase inhibitor, with additional activity against Epidermal Growth Factor. 38
A banking strategy toward customized therapy in breast cancer. 38
Reti dinamiche di apprendimento a distanza 38
ALTERATIONS OF AUTOPHAGIC FLUX IN CHARCOT-MARIE-TOOTH 2B DISEASE 38
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 37
Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma. 37
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells 37
Exploring the molecular aspects associated with testicular germ cell tumors: A review 37
Long-term cultures of stem/progenitor cells from lobular and ductal breastcarcinomas under non-adherent conditions. 36
Everolimus induces Met inactivation by disrupting the FKBP12/Met complex 36
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity. 34
Adenosine 3',5'-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL5 cells. 34
The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models. 33
Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences 33
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity 32
Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis. 32
Circulating and disseminated tumor cells from breast cancer patient 32
Iodine Inhibits the Proliferation of Rat-thyroid Cells In Culture 31
Antitumor activity of ZD6474, a small molecule VEGF receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to EGF receptor-targeted drugs. 31
AIRC Regional Grant ; “Breast cancer: preclinical and clinical development of therapeutic strategies targeting molecular mechanisms”. 30
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 29
Adenosine Has Divergent Effects On Deoxyribonucleic-acid Synthesis In Frtl5 Cells - Inhibition of Thyrotropin-stimulated and Potentiation of Insulin-like Growth Factor-i-stimulated Thymidine Incorporation 29
SRC INHIBITORS ACT THROUGH DIFFERENT MECHANISMS TO COOPERATE WITH EGFR OR MEK INHIBITORS IN NSCLC MODELS SENSITIVE OR RESISTANT TO ERLOTINIB 28
Annual Meeting of the ECTS Medical Association 27
P0081 Src inhibitors act through different mechanisms to cooperate with EGFR or MEK inhibitors in NSCLC models sensitive or resistant to erlotinib 27
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase 26
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 26
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 25
ADE-SOCRATES- Sperimentazione di e-learning su un corso di Attività Didattica Elettiva della Facoltà di Medicina e Chirurgia di Napoli “Federico II”. In: Reti dinamiche di apprendimento a distanza, U. Giani ed. Liguori Editore, pp. 345-350, 2004. ISBN: 88-207-3637-3 25
Endogenous IGF-II as a possible regulator of fetal rat thyroid gland development. 25
Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. 24
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective EGFR-tyrosine kinase inhibitor ZD1839 (‘Iressa’) 24
Principi di Patologia Generale 24
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. 24
Realizzazione e potenziamento di laboratori pubblici nei settori delle "scienze della nutrizione", "chirurgia avanzata" e "analisi dei tessuti". 24
Cells derived from normal or cancer breast tissue exhibit different growth properties when deprived of arginine. 24
Micrornas in prostate cancer: an overview 23
Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review 22
Expression of the Soluble Lectin L-14 Gene Is Induced By Tsh In Thyroid-cells and Suppressed By Retinoic Acid In Transformed Neural Cells 21
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity. 20
In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches. 20
Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299). 20
The disulfide bond pattern between fragments obtained by the limited proteolysis of bovine thyroglobulin. 20
IGF endogeno e proliferazione di tireociti. 20
SPHINGOSINE KINASE 1 (SPHK1) CONTRIBUTES TO RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITORS IN COLORECTAL CANCER MODELS 20
Expression of genes related to cell cycle in thyroid cells in culture. 19
Growth control of follicular cells in vitro. 19
INHIBITION OF CANCER CELL GROWTH AND INVASION BY TARGETING C-SRC IN BREAST CANCER MODELS RESISTANT TO ANTI-HER2 DRUGS 19
In the thyroid cells proliferation, differentiated and metabolic functions are under the control of different steps of the cyclic AMP cascade. 18
On the role of iodine on the proliferation of FRTL5 cells. 18
Adenosine has divergent effects on deoxyribonucleic acid synthesis in FRTL5 cells: inhibition of thyrotropin-stimulated and potentiation of insulin-like growth factor-I-stimulated thymidine incorporation. 18
Iodine inhibits thyroid cell proliferation through a cAMP-independent mechanism. 18
Ruolo di fattori di crescita autocrini nel controllo della proliferazione di cellule di tiroide di ratto in coltura. 17
The tissue-specific pathways regulating cell proliferation are inherited independently in somatic hybrid between thyroid and liver cells. 17
Elevated intracellular concentrations of cAMP act as a negative modulator of thyroid cell proliferation. 17
Studio GIM5: Studio di correlazione tra il gene CYP19 e l’efficacia di Letrozolo in pazienti in postmenopausa con tumore della mammella 17
Evidence of a biological role of an endogenous growth factor on the proliferation of rat thyroid cells. 17
Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences 17
Inibizione della proliferazione: ruolo del cAMP. 16
Iodine inhibits the proliferation of rat thyroid cells in culture. 16
Molecular mechanisms in tumorigenesis of poorly differentiated thyroid carcinomas. 16
Independent and interactive effects of tetradecanoyl phorbol acetate on growth and differentiated functions of FRTL5 cells. 16
Sustained versus transient cyclic AMP intracellular levels: effect on thyrotropin-dependent growth of thyroid cells. 16
Epithelial-mesenchymal transition in prostate cancer: an overview 16
Expression of the soluble lectin L-14 gene is induced by TSH in thyroid cells and suppressed by retinoic acid in transformed neural cells. 15
Endogenous IGFs modulates the mitogenic response of rat thyrocites in culture. 15
Dissociation and reassociation of non-covalently linked dimers of human 19S thyroglobulin treated with urea. 15
Condroitin-6-sulfate carbohydrate units. A major source of molecular microheterogeneity of human thyroglobulin. 15
Ottimizzazione di un modello di co-coltura da tessuto tumorale mammario per un approccio terapeutico personalizzato al paziente oncologico 15
Effect of serum on the proliferation induced by TSH and IGF-I in FRTL5 cells. 15
Oncotech 15
Increased bile acid excretion and reduction of serum cholesterol after crenotherapy with salt-rich mineral water 15
Epidermal Growth-factor Modulation of Tsh Mitogenic Activity 15
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). 14
Transfected insulin-like growth factor II modulates the mitogenic response of rat thyrocytes in culture. 14
TSH-EGF cooperation in the FRTL5 thyroid cell growth stimulation. 14
“Pharmacogenetics and endocrine therapy in postmenopausal early breast cancer patients. Correlation study of gene CYP19 and CYP2D6 polymorphisms with efficacy and toxicity” 13
TSH-EGF cooperation in the FRTL5 thyroid cell growth stimulation. 13
The role of TSH in the control of thyroid cell proliferation. 13
Transfected Insulin-like Growth Factor-ii Modulates the Mitogenic Response of Rat Thyrocytes In Culture 13
Issues of banking breast cancer cells to generate mammospheres. 13
Iodine inhibits the proliferation of rat thyroid cells. 12
Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity. 12
Polyacrylamide gel electrophoresis in discontinuous transverse urea-gradient gels. 12
Totale 2.884
Categoria #
all - tutte 11.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.707


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201931 0 0 0 0 0 0 0 0 0 10 7 14
2019/2020471 202 2 26 11 25 17 5 9 5 21 57 91
2020/2021320 12 15 32 24 28 40 19 19 52 13 46 20
2021/2022701 11 0 6 12 28 23 22 29 117 55 116 282
2022/2023605 124 43 20 23 65 60 2 51 72 106 28 11
2023/2024321 17 58 72 38 32 56 4 41 1 2 0 0
Totale 3.064